Abstract:Background: Blood-brain barrier (BBB) disruption is pivotal in the pathophysiological process of ischemic stroke and is often measured in rodent stroke studies. Traditionally, rodent BBB permeability increase is determined by measuring cerebral leakage of certain dyes such as Evans Blue or sodium fluorescein (NaFL). However, due to the special processing of samples for BBB permeability measurement, they cannot be used afterward for determining other essential parameters such as cerebral infarction volume. Therefore, using different batches of animals for assessing BBB permeability and infarction volume is typical. However, this would limit the stroke study's statistical power and scientific value while hindering the implementation of procedures for high standard animal welfare.New method: The rats subjected to middle cerebral artery occlusion (MCAO) were intraperitoneally injected with NaFL during the reperfusion phase. The brains were sliced and measured for BBB permeability using the small animal optical imaging system (IVIS (R) Lumia series III). Afterward, the same brain samples were either sliced or homogenized for tests that assessed infarction volume or other molecular changes.Results: The sum fluorescence intensity of the ischemic brain slices under the IVIS (R) Lumia series III showed a strong correlation with the infarction volume determined by 2,3,5-triphenyl tetrazolium chloride (TTC) staining (r = 0.7440, P = 0.0087). The fluorescence intensity of the whole ischemic brain was correlated with the NaFL concentration of brain tissue homogenates (r = 0.8653, P = 0.0026) and cerebral infarction volume (r = 0.7282, P = 0.0072).Comparison with existing methods: The new method enables concurrent measurement of BBB permeability and infarction volume on the same batch of brain tissue samples without affecting most downstream biochemical assays.Conclusions: By applying the new method, we could use the same batch of ischemic rodent brain tissue for multiple assays, including BBB permeability and infarction volume. Through this, we would reduce the animal numbers in each study and help to maximize the scientific and statistical potential of future rodent ischemic studies.

Albumin-seeking near-infrared-II probe evaluating blood–brain barrier disruption in stroke

A novel NIR-II albumin-escaping probe for cerebral arteries and perfusion imaging in stroke mice model

A Novel Near-Infrared-Ii Fluorescence Probe for Serum Albumin Biosensing and Site-Binding Mechanism Study

Targeting Blood-Brain Barrier Leakage for Visualizing, Monitoring, and Evaluating Ischemia Reperfusion Injury with Rus-Tc 99m Probe

Albumin-Consolidated AIEgens for Boosting Glioma and Cerebrovascular NIR-II Fluorescence Imaging

Targeting blood-brain barrier leakage for visualizing , monitoring, and evaluating ischemia reperfusion injury with Rus-Tc99m Probe

Blood–Brain Barrier Disruption and Imaging Assessment in Stroke

Site-specific Albumin Tagging with NIR-II Fluorogenic Dye for High-Performance and Super-Stable Bioimaging.

Evaluating Blood-Brain Barrier Disruption and Infarction Volume Concurrently in Rats Subjected to Ischemic Stroke Using an Optical Imaging System.

Biocompatible BSA-MnO2 nanoparticles for in vivo timely permeability imaging of blood-brain barrier and prediction of hemorrhage transformation in acute ischemic stroke

Biomarker and Drug Target Discovery Using Quantitative Proteomics Post-Intracerebral Hemorrhage Stroke in the Rat Brain

Human albumin aggravates cerebral edema by disrupting the blood‑brain barrier in a rat model of ischemic stroke

An Activatable NIR-II Nanoprobe for In Vivo Early Real-Time Diagnosis of Traumatic Brain Injury

Real-Time Tracking the Synthesis and Degradation of Albumin in Complex Biological Systems with A Near-Infrared Fluorescent Probe

Blood-brain barrier disruption measured by albumin index correlates with inflammatory fluid biomarkers

Physicochemical-property Guided Design of a Highly Sensitive Probe to Image Nitrosative Stress in the Pathology of Stroke

Multimodal nanoprobes evaluating physiological pore size of brain vasculatures in ischemic stroke models.

A Targeted Activatable NIR‐IIb Nanoprobe for Highly Sensitive Detection of Ischemic Stroke in a Photothrombotic Stroke Model

3D dynamic tracking Aβ plaques in live brains using vinyl-bridged dyes with two-photon excitation/NIR emission and large Stokes shifts

Visualization of Blood-Brain Barrier Disruption with Dual-Wavelength High-Resolution Photoacoustic Microscopy

NIR‐II Cyanine@albumin Fluorophore for Deep Tissue Imaging and Imaging‐guided Surgery